Pediatric cancer risk in association with birth defects: A systematic review

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Johnson, Kimberly J ^a,b   Lee, Jong Min ^a   Ahsan, Kazi ^a   Padda, Hannah ^a   Feng, Qianxi ^a   Partap, Sonia ^c   Fowler, Susan A ^a   Druley, Todd E ^b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BONE CANCER; BRAIN CANCER; CANCER RISK; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FEMALE; GERM CELL CANCER; GONAD TUMOR; HUMAN; INFANT; KIDNEY CANCER; LIVER CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PERIPHERAL NERVE TUMOR; RETINOBLASTOMA; REVIEW; SOFT TISSUE SARCOMA; SPINE CANCER; SYSTEMATIC REVIEW; TROPHOBLASTIC TUMOR; CASE CONTROL STUDY; COMPLICATION; CONGENITAL DISORDER; HEALTH CARE QUALITY; META ANALYSIS; NEOPLASM; PATHOLOGY; RISK FACTOR;

CASE-CONTROL STUDIES; CHILD; CONGENITAL ABNORMALITIES; HUMANS; NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS;

EID: 85026434156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0181246     Document Type: Review

References (111)

1. Centers for Disease Control and Prevention. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016 United States Cancer Statistics: 1999–2013 Incidence, WONDER Online Database [cited 2016 August 31]. http://wonder.cdc.gov/cancer-v2013.html
2. Centers for Disease Control and Prevention. Ten leading causes of death and injury by age group 2014 [cited 2016 August 31]. http://www.cdc.gov/injury/images/lc-charts/leading_causes_of_death_age_group_2014_1050w760h.gif.
3. Centers for Disease Control and Prevention. Facts about Birth Defects [updated 9/21/2015; cited 2016 November 23]. http://www.cdc.gov/ncbddd/birthdefects/facts.html.
4. New York State Department of Health. Congenital Malformations Registry—Summary Report: Appendix 1: Classification of Codes 2007 [cited 2016 December 13]. https://www.health.ny.gov/diseases/congenital_malformations/2002_2004/appendices.htm.
5. Texas Department of State Health Services. Minor Anomalies [cited 2016 12/16/2016]. https://www.dshs.texas.gov/genetics/pdf/anoma.pdf.
6. Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015; 373(24):2336–46. https://doi.org/10.1056/ NEJMoa1508054 PMID: 26580448;
7. Knapke S, Nagarajan R, Correll J, Kent D, Burns K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatric blood & cancer. 2012; 58(1):85–9. https://doi.org/10.1002/pbc. 23283 PMID: 21850677.
8. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. https://doi.org/10.1136/bmj. b2535 PMID: 19622551;
9. PubMed: National Center for Biotechnology Information [cited 2016 September 1]. http://www.ncbi.nlm.nih.gov/pubmed.
10. Embase Content [cited 2016 September 1]. https://www.elsevier.com/solutions/embase-biomedicalresearch/embase-coverage-and-content.
11. Little J. Epidemiology of childhood cancer. Lyon, Oxford: International Agency for Research on Cancer; Oxford University Press (distributor); 1999. xiv, 382 p. p.
12. Gelberg KH, Fitzgerald EF, Hwang S, Dubrow R. Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidemiol. 1997; 26(2):272–8. PMID: 9169161.
13. Wells GA, Shea, B., O’connell, D., Peterson, J. E. A., Welch, V., Losos, M., Tugwell, P.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses The Ottawa Hospital Research Institute [cited 2017 January 9]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
14. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005; 103(7):1457–67. https://doi.org/10.1002/cncr.20910 PMID: 15712273.
15. Savitz DA, Ananth CV. Birth characteristics of childhood cancer cases, controls, and their siblings. Pediatr Hematol Oncol. 1994; 11(6):587–99. PMID: 7857782.
16. Mann JR, Dodd HE, Draper GJ, Waterhouse JA, Birch JM, Cartwright RA, et al. Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC). Br J Cancer. 1993; 68(2):357–63. PMID: 8347491;
17. Altmann AE, Halliday JL, Giles GG. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer. 1998; 78(9):1244–9. PMID: 9820188;
18. Stewart A, Webb J, Hewitt D. A survey of childhood malignancies. Br Med J. 1958; 1(5086):1495–508. PMID: 13546604;
19. Mehes K, Signer E, Pluss HJ, Muller HJ, Stalder G. Increased prevalence of minor anomalies in childhood malignancy. Eur J Pediatr. 1985; 144(3):243–54. PMID: 4054163.
20. Durmaz A, Durmaz B, Kadioglu B, Aksoylar S, Karapinar D, Koturoglu G, et al. The Association of minor congenital anomalies and childhood cancer. Pediatric blood & cancer. 2011; 56(7):1098–102. https://doi.org/10.1002/pbc.23049 PMID: 21360657.
21. Merks JH, Ozgen HM, Koster J, Zwinderman AH, Caron HN, Hennekam RC. Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA. 2008; 299(1):61–9. https://doi.org/10.1001/jama.2007.66 PMID: 18167407.
22. Citak FE, Polat S, Citak EC. Minor anomalies in childhood lymphomas and solid tumors. J Pediatr Hematol Oncol. 2013; 35(1):42–5. https://doi.org/10.1097/MPH.0b013e318269b40b PMID: 23007416.
23. Schumacher R, Mai A, Gutjahr P. Association of rib anomalies and malignancy in childhood. Eur J Pediatr. 1992; 151(6):432–4. PMID: 1628671.
24. Zierhut H, Murati M, Holm T, Hoggard E, Spector LG. Association of rib anomalies and childhood cancers. Br J Cancer. 2011; 105(9):1392–5. https://doi.org/10.1038/bjc.2011.366 PMID: 21915120;
25. Loder RT, Huffman G, Toney E, Wurtz LD, Fallon R. Abnormal rib number in childhood malignancy: implications for the scoliosis surgeon. Spine (Phila Pa 1976). 2007; 32(8):904–10. https://doi.org/10.1097/01.brs.0000259834.28893.97 PMID: 17426637.
26. Merks JH, Smets AM, Van Rijn RR, Kobes J, Caron HN, Maas M, et al. Prevalence of rib anomalies in normal Caucasian children and childhood cancer patients. Eur J Med Genet. 2005; 48(2):113–29. https://doi.org/10.1016/j.ejmg.2005.01.029 PMID: 16053903.
27. Windham GC, Bjerkedal T, Langmark F. A population-based study of cancer incidence in twins and in children with congenital malformations or low birth weight, Norway, 1967–1980. Am J Epidemiol. 1985; 121(1):49–56. PMID: 3155484.
28. Mili F, Khoury MJ, Flanders WD, Greenberg RS. Risk of childhood cancer for infants with birth defects. I. A record-linkage study, Atlanta, Georgia, 1968–1988. Am J Epidemiol. 1993; 137(6):629–38. PMID: 8470664.
29. Mili F, Lynch CF, Khoury MJ, Flanders WD, Edmonds LD. Risk of childhood cancer for infants with birth defects. II. A record-linkage study, Iowa, 1983–1989. Am J Epidemiol. 1993; 137(6):639–44. PMID: 8470665.
30. Rankin J, Silf KA, Pearce MS, Parker L, Ward Platt M. Congenital anomaly and childhood cancer: A population-based, record linkage study. Pediatric blood & cancer. 2008; 51(5):608–12. https://doi.org/10.1002/pbc.21682 PMID: 18623214.
31. Carozza SE, Langlois PH, Miller EA, Canfield M. Are children with birth defects at higher risk of childhood cancers? Am J Epidemiol. 2012; 175(12):1217–24. https://doi.org/10.1093/aje/kwr470 PMID: 22534203.
32. Botto LD, Flood T, Little J, Fluchel MN, Krikov S, Feldkamp ML, et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One. 2013; 8(7):e69077. https://doi.org/10.1371/journal.pone.0069077 PMID: 23874873;
33. Agha MM, Williams JI, Marrett L, To T, Zipursky A, Dodds L. Congenital abnormalities and childhood cancer. Cancer. 2005; 103(9):1939–48. https://doi.org/10.1002/cncr.20985 PMID: 15770693.
34. Dawson S, Charles AK, Bower C, de Klerk NH, Milne E. Risk of cancer among children with birth defects: a novel approach. Birth defects research Part A, Clinical and molecular teratology. 2015; 103 (4):284–91. https://doi.org/10.1002/bdra.23364 PMID: 25808250.
35. Janitz AE, Neas BR, Campbell JE, Pate AE, Stoner JA, Magzamen SL, et al. Childhood cancer in children with congenital anomalies in Oklahoma, 1997 to 2009. Birth defects research Part A, Clinical and molecular teratology. 2016; 106(7):633–42. https://doi.org/10.1002/bdra.23494 PMID: 26945683;
36. Fisher PG, Reynolds P, Von Behren J, Carmichael SL, Rasmussen SA, Shaw GM. Cancer in children with nonchromosomal birth defects. J Pediatr. 2012; 160(6):978–83. https://doi.org/10.1016/j.jpeds.2011.12.006 PMID: 22244463;
37. Johnson KJ, Spector LG, Klebanoff MA, Ross JA. Childhood cancer and birthmarks in the Collaborative Perinatal Project. Pediatrics. 2007; 119(5):e1088–93. https://doi.org/10.1542/peds.2006-2315PMID: 17473081.
38. Sun Y, Overvad K, Olsen J. Cancer risks in children with congenital malformations in the nervous and circulatory system-A population based cohort study. Cancer epidemiology. 2014; 38(4):393–400. https://doi.org/10.1016/j.canep.2014.04.001 PMID: 24802852.
39. Ager EA, Schuman LM, Wallace HM, Rosenfield AB, Gullen WH. An Epidemiological Study of Childhood Leukemia. J Chronic Dis. 1965; 18:113–32. PMID: 14258467.
40. Zack M, Adami HO, Ericson A. Maternal and perinatal risk factors for childhood leukemia. Cancer Res. 1991; 51(14):3696–701. PMID: 2065325.
41. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1995; 4(5):441–5. PMID: 7549797.
42. Infante-Rivard C, Amre DK. Congenital anomalies in children with acute lymphoblastic leukaemia and in their family. Int J Epidemiol. 2001; 30(2):350–2. PMID: 11369741.
43. Mertens AC, Wen W, Davies SM, Steinbuch M, Buckley JD, Potter JD, et al. Congenital abnormalities in children with acute leukemia: a report from the Children’s Cancer Group. J Pediatr. 1998; 133 (5):617–23. PMID: 9821417.
44. Podvin D, Kuehn CM, Mueller BA, Williams M. Maternal and birth characteristics in relation to childhood leukaemia. Paediatr Perinat Epidemiol. 2006; 20(4):312–22. https://doi.org/10.1111/j.13653016.2006.00731.x PMID: 16879503.
45. Rudant J, Amigou A, Orsi L, Althaus T, Leverger G, Baruchel A, et al. Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). Pediatric blood & cancer. 2013; 60(2):301–8. https://doi.org/10.1002/pbc.24192 PMID: 22610722.
46. Johnson KJ, Roesler MA, Linabery AM, Hilden JM, Davies SM, Ross JA. Infant leukemia and congenital abnormalities: a Children’s Oncology Group study. Pediatric blood & cancer. 2010; 55(1):95–9. https://doi.org/10.1002/pbc.22495 PMID: 20486175;
47. Magnani C, Pastore G, Luzzatto L, Terracini B. Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin’s lymphomas in childhood: a case-control study. Tumori. 1990; 76(5):413–9. PMID: 2256184.
48. Shu XO, Gao YT, Brinton LA, Linet MS, Tu JT, Zheng W, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer. 1988; 62(3):635–44. PMID: 3164642.
49. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst. 1995; 87(12):908–14. PMID: 7666480.
50. Roganovic J, Radojcic-Badovinac A, Ahel V. Increased prevalence of minor anomalies in children with hematologic malignancies. Med Pediatr Oncol. 2002; 38(2):128–30. PMID: 11813182.
51. Citak FE, Citak EC, Akkaya E, Kosan B, Ezer U, Kurekci AE. Minor anomalies in children with hematological malignancies. Pediatric blood & cancer. 2011; 56(2):258–61. https://doi.org/10.1002/pbc. 22689 PMID: 20860040.
52. Mehes K, Kajtar P, Sandor G, Scheel-Walter M, Niethammer D. Excess of mild errors of morphogenesis in childhood lymphoblastic leukemia. Am J Med Genet. 1998; 75(1):22–7. PMID: 9450852.
53. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet. 1997; 60(3):474–85. PMID: 9042906;
54. Adami J, Glimelius B, Cnattingius S, Ekbom A, Zahm SH, Linet M, et al. Maternal and perinatal factors associated with non-Hodgkin’s lymphoma among children. International journal of cancer. 1996; 65 (6):774–7. https://doi.org/10.1002/(SICI)1097-0215(19960315)65:6〈774::AID-IJC11〉3.0.CO;2-4PMID: 8631590.
55. Baptiste M, Nasca P, Metzger B, Field N, MacCubbin P, Greenwald P, et al. Neurofibromatosis and other disorders among children with CNS tumors and their families. Neurology. 1989; 39(4):487–92. PMID: 2494566.
56. Birch JM, Hartley AL, Teare MD, Blair V, McKinney PA, Mann JR, et al. The inter-regional epidemiological study of childhood cancer (IRESCC): case-control study of children with central nervous system tumours. Br J Neurosurg. 1990; 4(1):17–25. PMID: 2334522.
57. Partap S, MacLean J, Von Behren J, Reynolds P, Fisher PG. Birth anomalies and obstetric history as risks for childhood tumors of the central nervous system. Pediatrics. 2011; 128(3):e652–7. https://doi.org/10.1542/peds.2010-3637 PMID: 21824884;
58. Mallol-Mesnard N, Menegaux F, Lacour B, Hartmann O, Frappaz D, Doz F, et al. Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer). Cancer Detect Prev. 2008; 32(1):79–86. https://doi.org/10.1016/j.cdp.2008.02.003PMID: 18396378.
59. Bailey HD, Rios P, Lacour B, Guerrini-Rousseau L, Bertozzi AI, Leblond P, et al. Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France). International journal of cancer. 2017; 140(8):1757–69. https://doi.org/10.1002/ijc. 30597 PMID: 28054353.
60. Greenop KR, Blair EM, Bower C, Armstrong BK, Milne E. Factors relating to pregnancy and birth and the risk of childhood brain tumors: results from an Australian case-control study. Pediatric blood & cancer. 2014; 61(3):493–8. https://doi.org/10.1002/pbc.24751 PMID: 24039139.
61. Cordier S, Iglesias MJ, Le Goaster C, Guyot MM, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. International journal of cancer. 1994; 59(6):776–82. PMID: 7989118.
62. Johnson CC, Annegers JF, Frankowski RF, Spitz MR, Buffler PA. Childhood nervous system tumors —an evaluation of the association with paternal occupational exposure to hydrocarbons. Am J Epidemiol. 1987; 126(4):605–13. PMID: 3631052.
63. Linet MS, Gridley G, Cnattingius S, Nicholson HS, Martinsson U, Glimelius B, et al. Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control. 1996; 7(4):437–48. PMID: 8813432.
64. Gold EB, Leviton A, Lopez R, Austin DF, Gilles FH, Hedley-Whyte ET, et al. The role of family history in risk of childhood brain tumors. Cancer. 1994; 73(4):1302–11. PMID: 8313335.
65. McCredie M, Maisonneuve P, Boyle P. Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. International journal of cancer. 1994; 56(1):11–5. PMID: 8262665.
66. Johnson CC, Spitz MR. Neuroblastoma: case-control analysis of birth characteristics. J Natl Cancer Inst. 1985; 74(4):789–92. PMID: 3857376.
67. Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL. Prenatal and perinatal risk factors for neuroblastoma. A case-control study. Cancer. 1988; 61(11):2202–6. PMID: 3365650.
68. Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS. Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol. 2001; 15(1):47–53. PMID: 11237115.
69. Munzer C, Menegaux F, Lacour B, Valteau-Couanet D, Michon J, Coze C, et al. Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE). International journal of cancer. 2008; 122(10):2315–21. https://doi.org/10.1002/ijc. 23301 PMID: 18076072;
70. Chow EJ, Friedman DL, Mueller BA. Maternal and perinatal characteristics in relation to neuroblastoma. Cancer. 2007; 109(5):983–92. https://doi.org/10.1002/cncr.22486 PMID: 17285600.
71. Menegaux F, Olshan AF, Reitnauer PJ, Blatt J, Cohn SL. Positive association between congenital anomalies and risk of neuroblastoma. Pediatric blood & cancer. 2005; 45(5):649–55. https://doi.org/10.1002/pbc.20263 PMID: 15547919.
72. Parodi S, Merlo DF, Ranucci A, Miligi L, Benvenuti A, Rondelli R, et al. Risk of neuroblastoma, maternal characteristics and perinatal exposures: the SETIL study. Cancer epidemiology. 2014; 38(6):686–94. https://doi.org/10.1016/j.canep.2014.09.007 PMID: 25280392.
73. Urayama KY, Von Behren J, Reynolds P. Birth characteristics and risk of neuroblastoma in young children. Am J Epidemiol. 2007; 165(5):486–95. https://doi.org/10.1093/aje/kwk041 PMID: 17164463.
74. Rios P, Bailey HD, Orsi L, Lacour B, Valteau-Couanet D, Levy D, et al. Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE). International journal of cancer. 2016; 139(9):1936–48. https://doi.org/10.1002/ijc.30239 PMID: 27342419.
75. Bjorge T, Engeland A, Tretli S, Heuch I. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. Br J Cancer. 2008; 99(7):1165–9. https://doi.org/10.1038/sj.bjc.6604646 PMID: 18766190;
76. Johnson KJ, Puumala SE, Soler JT, Spector LG. Perinatal characteristics and risk of neuroblastoma. International journal of cancer. 2008; 123(5):1166–72. https://doi.org/10.1002/ijc.23645 PMID: 18546287.
77. Wilkins JR 3rd, Sinks TH Jr. Paternal occupation and Wilms’ tumour in offspring. J Epidemiol Community Health. 1984; 38(1):7–11. PMID: 6323612;
78. Bunin GR, Kramer S, Marrero O, Meadows AT. Gestational risk factors for Wilms’ tumor: results of a case-control study. Cancer Res. 1987; 47(11):2972–7. PMID: 3032418.
79. Kajtar P, Weisenbach J, Mehes K. Association of Wilms tumour with spina bifida occulta. Eur J Pediatr. 1990; 149(8):594–5. PMID: 2161343.
80. Mehes K, Weisenbach J, Kajtar P. Association of wilms tumor with spinal dysraphism. Pediatr Hematol Oncol. 2003; 20(3):261–4. PMID: 12637224.
81. Lindblad P, Zack M, Adami HO, Ericson A. Maternal and perinatal risk factors for Wilms’ tumor: a nationwide nested case-control study in Sweden. International journal of cancer. 1992; 51(1):38–41. PMID: 1314230.
82. Puumala SE, Soler JT, Johnson KJ, Spector LG. Birth characteristics and Wilms tumor in Minnesota. International journal of cancer. 2008; 122(6):1368–73. https://doi.org/10.1002/ijc.23275 PMID: 18033684.
83. Breslow NE, Beckwith JB. Epidemiological features of Wilms’ tumor: results of the National Wilms’ Tumor Study. J Natl Cancer Inst. 1982; 68(3):429–36. PMID: 6278194.
84. Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, et al. Congenital abnormalities and hepatoblastoma: a report from the Children’s Oncology Group (COG) and the Utah Population Database (UPDB). American journal of medical genetics Part A. 2014; 164A(9):2250–5. https://doi.org/10.1002/ajmg.a.36638 PMID: 24934283;
85. Spector LG, Johnson KJ, Soler JT, Puumala SE. Perinatal risk factors for hepatoblastoma. Br J Cancer. 2008; 98(9):1570–3. https://doi.org/10.1038/sj.bjc.6604335 PMID: 18392049;
86. Yang P, Grufferman S, Khoury MJ, Schwartz AG, Kowalski J, Ruymann FB, et al. Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects. Genet Epidemiol. 1995; 12 (5):467–74. https://doi.org/10.1002/gepi.1370120504 PMID: 8557179.
87. Ruymann FB, Maddux HR, Ragab A, Soule EH, Palmer N, Beltangady M, et al. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children’s Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children’s Cancer Study Group, and the Pediatric Intergroup Statistical Center). Med Pediatr Oncol. 1988; 16(1):33–9. PMID: 3277029.
88. Johnson KJ, Ross JA, Poynter JN, Linabery AM, Robison LL, Shu XO. Paediatric germ cell tumours and congenital abnormalities: a Children’s Oncology Group study. Br J Cancer. 2009; 101(3):518–21. https://doi.org/10.1038/sj.bjc.6605169 PMID: 19603020;
89. Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robinson LL. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States). Cancer Causes Control. 1995; 6(3):187–98. PMID: 7612798.
90. Hall C, Ritz B, Cockburn M, Davidson TB, Heck JE. Risk of malignant childhood germ cell tumors in relation to demographic, gestational, and perinatal characteristics. Cancer epidemiology. 2017; 46:42–9. https://doi.org/10.1016/j.canep.2016.12.002 PMID: 28013088;
91. Swerdlow AJ, Stiller CA, Wilson LM. Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953–73. J Epidemiol Community Health. 1982; 36(2):96–101. PMID: 7119662;
92. Wanderas EH, Grotmol T, Fossa SD, Tretli S. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control. 1998; 9(5):475–86. PMID: 9934714.
93. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, et al. Guidelines for case classification for the National Birth Defects Prevention Study. Birth defects research Part A, Clinical and molecular teratology. 2003; 67(3):193–201. https://doi.org/10.1002/bdra.10012 PMID: 12797461.
94. Bjorge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008; 17(3):500–6. https:// doi.org/10.1158/1055-9965.EPI-07-2630 PMID: 18296646.
95. Online Mendelian Inheritance in Man. Chromosome 13q14 deletion syndrome [cited 2016 November 23]. http://www.omim.org/entry/613884
96. Lohmann DR, Gallie BL. Retinoblastoma. 2000 Jul 18 [Updated 2015 Nov 19]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK1452/.
97. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, et al. Requirement for a functional Rb-1 gene in murine development. Nature. 1992; 359(6393):328–30. https://doi.org/10.1038/359328a0 PMID: 1406937.
98. U.S. National Library of Medicine. WAGR syndrome [cited 2016 August 2]. https://ghr.nlm.nih.gov/condition/wagr-syndrome#genes.
99. Jiang M, Stanke J, Lahti JM. The connections between neural crest development and neuroblastoma. Curr Top Dev Biol. 2011; 94:77–127. https://doi.org/10.1016/B978-0-12-380916-2.00004-8 PMID: 21295685;
100. Grimmer MR, Weiss WA. Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr. 2006; 18(6):634–8. https://doi.org/10.1097/MOP.0b013e32801080fe PMID: 17099362.
101. Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol Med. 2005; 11 (1):17–22. https://doi.org/10.1016/j.molmed.2004.11.008 PMID: 15649818.
102. Scotting PJ, Walker DA, Perilongo G. Childhood solid tumours: a developmental disorder. Nat Rev Cancer. 2005; 5(6):481–8. https://doi.org/10.1038/nrc1633 PMID: 15905853.
103. Wiemels J. Perspectives on the causes of childhood leukemia. Chem Biol Interact. 2012; 196(3):59–67. https://doi.org/10.1016/j.cbi.2012.01.007 PMID: 22326931;
104. U.S. National Library of Medicine. Beckwith-Wiedemann syndrome [cited 2016 August 2]. https://www.ghr.nlm.nih.gov/condition/beckwith-wiedemann-syndrome.
105. National Institutes of Health Office of Management. Systematic Reviews: The Literature Search—Databases and Gray Literature [cited 2016 December 16]. http://nihlibrary.campusguides.com/c.php?g=38332&p=244522.
106. Savitz DA, Wachtel H, Barnes FA, John EM, Tvrdik JG. Case-control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol. 1988; 128(1):21–38. PMID: 3164167.
107. Merks JH, van Karnebeek CD, Caron HN, Hennekam RC. Phenotypic abnormalities: terminology and classification. American journal of medical genetics Part A. 2003; 123A(3):211–30. https://doi.org/10.1002/ajmg.a.20249 PMID: 14608641.
108. Milne E, Greenop KR, Bower C, Miller M, van Bockxmeer FM, Scott RJ, et al. Maternal use of folic acid and other supplements and risk of childhood brain tumors. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012; 21(11):1933–41. https://doi.org/10.1158/1055-9965.EPI-12-0803 PMID: 22941336.
109. Santos AC, Heck B, Camargo BD, Vargas FR. Prevalence of Cafe-au-Lait Spots in children with solid tumors. Genetics and molecular biology. 2016; 39(2):232–8. https://doi.org/10.1590/1678-4685-GMB-2015-0024 PMID: 27223488;
110. National Wilms Tumor Study [cited 2016 August 11]. http://www.nwtsg.org/about/about.html.
111. Pinsky L. Informative morphogenetic variants. Minor congenital anomalies revisited. In: Kalter, editor. Issues and Reviews in Teratology. 3. New York: Plenum; 1985. p. 135–70.